Adenylate cyclase and the cyclic AMP receptor protein modulate stress resistance and virulence capacity of uropathogenic Escherichia coli

Infection and Immunity

Volumn 81, Issue 1, 2013, Pages 249-258

  Donovan, Grant T ^a   Paul Norton, J ^a   Bower, Jean M ^a,b   Mulvey, Matthew A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b SALT LAKE COMMUNITY COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; AMINO ACID; CATALASE; CYCLIC AMP; CYCLIC AMP BINDING PROTEIN; DPS PROTEIN; GLUCOSE; HYDROGEN PEROXIDE; LACTOSE; PARAQUAT; SIGMA FACTOR RPOS;

ACIDITY; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CARBOHYDRATE METABOLISM; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI INFECTION; FEMALE; GENE DELETION; INNATE IMMUNITY; MOUSE; NITROSATIVE STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UROPATHOGENIC ESCHERICHIA COLI; WILD TYPE;

ADENYLATE CYCLASE; AMINO ACIDS; ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CYCLIC AMP; CYCLIC AMP RECEPTOR PROTEIN; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; GLUCOSE; HYDROGEN PEROXIDE; LACTOSE; MICE; MICE, INBRED C3H; MICE, INBRED CBA; PARAQUAT; SIGMA FACTOR; SUPEROXIDES; URINARY BLADDER; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

EID: 84871870900     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00796-12     Document Type: Article

References (84)

1. Wiles TJ, Kulesus RR, Mulvey MA. 2008. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85:11-19.
2. Zasloff M. 2007. Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J. Am. Soc. Nephrol. 18:2810-2816.
3. Gawel D, Seed PC. 2011. Urinary tract infection drives genome instability in uropathogenic Escherichia coli and necessitates translesion synthesis DNA polymerase IV for virulence. Virulence 2:222-232.
4. Alteri CJ, Mobley HL. 2012. Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Curr. Opin. Microbiol. 15:3-9.
5. Li B, Smith P, Horvath DJ, Jr, Romesberg FE, Justice SS. 2010. SOS regulatory elements are essential for UPEC pathogenesis. Microbes Infect. 12:662-668.
6. Foxman B. 2010. The epidemiology of urinary tract infection. Nat. Rev. Urol. 7:653-660.
7. Sivick KE, Mobley HL. 2010. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect. Immun. 78:568-585.
8. Hunstad DA, Justice SS. 2010. Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu. Rev. Microbiol. 64:203-221.
9. Dhakal BK, Kulesus RR, Mulvey MA. 2008. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur. J. Clin. Invest. 38(S2):2-11.
10. Alteri CJ, Smith SN, Mobley HL. 2009. Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog. 5:e1000448. doi:10.1371/journal.ppat.1000448.
11. Martinez-Jehanne V, Pichon C, du Merle L, Poupel O, Cayet N, Bouchier C, Le Bouguenec C. 2012. Role of the Vpe carbohydrate permease in Escherichia coli urovirulence and fitness in vivo. Infect. Immun. 80:2655-2666.
12. Anfora AT, Haugen BJ, Roesch P, Redford P, Welch RA. 2007. Roles of serine accumulation and catabolism in the colonization of the murine urinary tract by Escherichia coli CFT073. Infect. Immun. 75:5298-5304.
13. Roesch PL, Redford P, Batchelet S, Moritz RL, Pellett S, Haugen BJ, Blattner FR, Welch RA. 2003. Uropathogenic Escherichia coli use d-serine deaminase to modulate infection of the murine urinary tract. Mol. Microbiol. 49:55-67.
14. Hadjifrangiskou M, Kostakioti M, Chen SL, Henderson JP, Greene SE, Hultgren SJ. 2011. A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol. Microbiol. 80:1516-1529.
15. Kostakioti M, Hadjifrangiskou M, Pinkner JS, Hultgren SJ. 2009. QseC-mediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli. Mol. Micro-biol. 73:1020-1031.
16. Gorke B, Stulke J. 2008. Carbon catabolite repression in bacteria: many ways to make the most out of nutrients. Nat. Rev. Microbiol. 6:613-624.
17. Poncet S, Milohanic E, Maze A, Nait Abdallah J, Ake F, Larribe M, Deghmane AE, Taha MK, Dozot M, De Bolle X, Letesson JJ, Deutscher J. 2009. Correlations between carbon metabolism and virulence in bacteria. Contrib. Microbiol. 16:88-102.
18. McDonough KA, Rodriguez A. 2012. The myriad roles of cyclic AMP in microbial pathogens: from signal to sword. Nat. Rev. Microbiol. 10:27-38.
19. Nielsen AT, Dolganov NA, Rasmussen T, Otto G, Miller MC, Felt SA, Torreilles S, Schoolnik GK. 2010. A bistable switch and anatomical site control Vibrio cholerae virulence gene expression in the intestine. PLoS Pathog. 6:e1001102. doi:10.1371/journal.ppat.1001102.
20. Rickman L, Scott C, Hunt DM, Hutchinson T, Menendez MC, Whalan R, Hinds J, Colston MJ, Green J, Buxton RS. 2005. A member of the cAMP receptor protein family of transcription regulators in Mycobacterium tuberculosis is required for virulence in mice and controls transcription of the rpfA gene coding for a resuscitation promoting factor. Mol. Microbiol. 56:1274-1286.
21. Curtiss R, III, Kelly SM. 1987. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 55:3035-3043.
22. Smith RS, Wolfgang MC, Lory S. 2004. An adenylate cyclase-controlled signaling network regulates Pseudomonas aeruginosa virulence in a mouse model of acute pneumonia. Infect. Immun. 72:1677-1684.
23. Muller CM, Aberg A, Straseviciene J, Emody L, Uhlin BE, Balsalobre C. 2009. Type 1 fimbriae, a colonization factor of uropathogenic Escherichia coli, are controlled by the metabolic sensor CRP-cAMP. PLoS Pathog. 5:e1000303. doi:10.1371/journal.ppat.1000303.
24. Chen SL, Hung CS, Xu J, Reigstad CS, Magrini V, Sabo A, Blasiar D, Bieri T, Meyer RR, Ozersky P, Armstrong JR, Fulton RS, Latreille JP, Spieth J, Hooton TM, Mardis ER, Hultgren SJ, Gordon JI. 2006. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc. Natl. Acad. Sci. U. S. A. 103:5977-5982.
25. Mulvey MA, Schilling JD, Hultgren SJ. 2001. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 69:4572-4579.
26. Zhou Q, Ames P, Parkinson JS. 2009. Mutational analyses of HAMP helices suggest a dynamic bundle model of input-output signalling in chemoreceptors. Mol. Microbiol. 73:801-814.
27. Murphy KC, Campellone KG. 2003. Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli. BMC Mol. Biol. 4:11. doi:10.1186/1471-2199-4-11.
28. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
29. Blango MG, Mulvey MA. 2010. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob. Agents Chemother. 54:1855-1863.
30. Eto DS, Gordon HB, Dhakal BK, Jones TA, Mulvey MA. 2008. Clathrin, AP-2, and the NPXY-binding subset of alternate endocytic adaptors facilitate FimH-mediated bacterial invasion of host cells. Cell. Microbiol. 10: 2553-2567.
31. Hopkins W, Gendron-Fitzpatrick A, McCarthy DO, Haine JE, Uehling DT. 1996. Lipopolysaccharide-responder and nonresponder C3H mouse strains are equally susceptible to an induced Escherichia coli urinary tract infection. Infect. Immun. 64:1369-1372.
32. Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, Svanborg Eden C. 1984. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect. Immun. 46:839-844.
33. Suhs KA, Marthaler BR, Welch RA, Hopkins WJ. 2011. Lack of association between the Tlr4 (Lpsd/Lpsd) genotype and increased susceptibility to Escherichia coli bladder infections in female C3H/HeJ mice. mBio 2:e00094-11. doi:10.1128/mBio.00094-11.
34. Hopkins WJ, Elkahwaji J, Kendziorski C, Moser AR, Briggs PM, Suhs KA. 2009. Quantitative trait loci associated with susceptibility to bladder and kidney infections induced by Escherichia coli in female C3H/HeJ mice. J. Infect. Dis. 199:355-361.
35. Haraoka M, Hang L, Frendéacute;us B, Godaly G, Burdick M, Strieter R, Svanborg C. 1999. Neutrophil recruitment and resistance to urinary tract infection. J. Infect. Dis. 180:1220-1229.
36. Schilling JD, Martin SM, Hung CS, Lorenz RG, Hultgren SJ. 2003. Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 100:4203-4208.
37. Aubron C, Glodt J, Matar C, Huet O, Borderie D, Dobrindt U, Duranteau J, Denamur E, Conti M, Bouvet O. 2012. Variation in endogenous oxidative stress in Escherichia coli natural isolates during growth in urine. BMC Microbiol. 12:120. doi:10.1186/1471-2180-12-120.
38. Bower JM, Gordon-Raagas HB, Mulvey MA. 2009. Conditioning of uropathogenic Escherichia coli for enhanced colonization of host. Infect. Immun. 77:2104-2112.
39. Johnson JR, Clabots C, Rosen H. 2006. Effect of inactivation of the global oxidative stress regulator oxyR on the colonization ability of Escherichia coli O1:K1:H7 in a mouse model of ascending urinary tract infection. Infect. Immun. 74:461-468.
40. Korshunov S, Imlay JA. 2006. Detection and quantification of superoxide formed within the periplasm of Escherichia coli. J. Bacteriol. 188:6326-6334.
41. Lundberg JO, Ehren I, Jansson O, Adolfsson J, Lundberg JM, Weitzberg E, Alving K, Wiklund NP. 1996. Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis. Urology 48:700-702.
42. Poljakovic M, Svensson ML, Svanborg C, Johansson K, Larsson B, Persson K. 2001. Escherichia coli-induced inducible nitric oxide synthase and cyclooxygenase expression in the mouse bladder and kidney. Kidney Int. 59:893-904.
43. Woolford G, Casselden RJ, Walters CL. 1972. Gaseous products of the interaction of sodium nitrite with porcine skeletal muscle. Biochem. J. 130:82P-83P.
44. Barth E, Gora KV, Gebendorfer KM, Settele F, Jakob U, Winter J. 2009. Interplay of cellular cAMP levels, {sigma}S activity and oxidative stress resistance in Escherichia coli. Microbiology 155:1680-1689.
45. Hengge-Aronis R. 2002. Signal transduction and regulatory mechanisms involved in control of the sigma(S) (RpoS) subunit of RNA polymerase. Microbiol. Mol. Biol. Rev. 66:373-395.
46. Jeong KC, Baumler DJ, Kaspar CW. 2006. dps expression in Escherichia coli O157:H7 requires an extended -10 region and is affected by the cAMP receptor protein. Biochim. Biophys. Acta 1759:51-59.
47. Lange R, Hengge-Aronis R. 1994. The cellular concentration of the sigma S subunit of RNA polymerase in Escherichia coli is controlled at the levels of transcription, translation, and protein stability. Genes Dev. 8:1600-1612.
48. Eisenstark A, Calcutt MJ, Becker-Hapak M, Ivanova A. 1996. Role of Escherichia coli rpoS and associated genes in defense against oxidative damage. Free Radic. Biol. Med. 21:975-993.
49. Schellhorn HE. 1995. Regulation of hydroperoxidase (catalase) expression in Escherichia coli. FEMS Microbiol. Lett. 131:113-119.
50. Strom AR, Kaasen I. 1993. Trehalose metabolism in Escherichia coli: stress protection and stress regulation of gene expression. Mol. Microbiol. 8:205-210.
51. Alvarez-Peral FJ, Zaragoza O, Pedreno Y, Arguelles JC. 2002. Protective role of trehalose during severe oxidative stress caused by hydrogen peroxide and the adaptive oxidative stress response in Candida albicans. Micro-biology 148:2599-2606.
52. Benaroudj N, Lee DH, Goldberg AL. 2001. Trehalose accumulation during cellular stress protects cells and cellular proteins from damage by oxygen radicals. J. Biol. Chem. 276:24261-24267.
53. Martinez A, Kolter R. 1997. Protection of DNA during oxidative stress by the nonspecific DNA-binding protein Dps. J. Bacteriol. 179:5188-5194.
54. Almiron M, Link AJ, Furlong D, Kolter R. 1992. A novel DNA-binding protein with regulatory and protective roles in starved Escherichia coli. Genes Dev. 6:2646-2654.
55. Park S, You X, Imlay JA. 2005. Substantial DNA damage from submicromolar intracellular hydrogen peroxide detected in Hpx-mutants of Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 102:9317-9322.
56. Eto DS, Sundsbak JL, Mulvey MA. 2006. Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell. Microbiol. 8:704-717.
57. Vergne I, Constant P, Laneelle G. 1998. Phagosomal pH determination by dual fluorescence flow cytometry. Anal. Biochem. 255:127-132.
58. Foster JW. 2004. Escherichia coli acid resistance: tales of an amateur acidophile. Nat. Rev. Microbiol. 2:898-907.
59. Castanie-Cornet MP, Penfound TA, Smith D, Elliott JF, Foster JW. 1999. Control of acid resistance in Escherichia coli. J. Bacteriol. 181:3525-3535.
60. Calhoun LN, Kwon YM. 2011. Structure, function and regulation of the DNA-binding protein Dps and its role in acid and oxidative stress resistance in Escherichia coli: a review. J. Appl. Microbiol. 110:375-386.
61. Small P, Blankenhorn D, Welty D, Zinser E, Slonczewski JL. 1994. Acid and base resistance in Escherichia coli and Shigella flexneri: role of rpoS and growth pH. J. Bacteriol. 176:1729-1737.
62. Cheville AM, Arnold KW, Buchrieser C, Cheng CM, Kaspar CW. 1996. rpoS regulation of acid, heat, and salt tolerance in Escherichia coli O157: H7. Appl. Environ. Microbiol. 62:1822-1824.
63. Waterman SR, Small PL. 1996. Characterization of the acid resistance phenotype and rpoS alleles of Shiga-like toxin-producing Escherichia coli. Infect. Immun. 64:2808-2811.
64. Le Bouguenec C, Schouler C. 2011. Sugar metabolism, an additional virulence factor in enterobacteria. Int. J. Med. Microbiol. 301:1-6.
65. Loughman JA, Hunstad DA. 2012. Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection. J. Infect. Dis. 205:1830-1839.
66. Rouquet G, Porcheron G, Barra C, Reperant M, Chanteloup NK, Schouler C, Gilot P. 2009. A metabolic operon in extraintestinal pathogenic Escherichia coli promotes fitness under stressful conditions and invasion of eukaryotic cells. J. Bacteriol. 191:4427-4440.
67. Himpsl SD, Lockatell CV, Hebel JR, Johnson DE, Mobley HL. 2008. Identification of virulence determinants in uropathogenic Proteus mirabilis using signature-tagged mutagenesis. J. Med. Microbiol. 57:1068-1078.
68. Gonzalez-Flecha B, Demple B. 1997. Transcriptional regulation of the Escherichia coli oxyR gene as a function of cell growth. J. Bacteriol. 179: 6181-6186.
69. Kostakioti M, Hadjifrangiskou M, Cusumano CK, Hannan TJ, Janetka JW, Hultgren SJ. 2012. Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during uri-nary tract infection. Infect. Immun. 80:2826-2834.
70. Poljakovic M, Karpman D, Svanborg C, Persson K. 2002. Human renal epithelial cells express iNOS in response to cytokines but not bacteria. Kidney Int. 61:444-455.
71. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088.
72. McAdam KP, Ryan JL. 1978. C57BL/10/CR mice: nonresponders to activation by the lipid a moiety of bacterial lipopolysaccharide. J. Immun. 120:249-253.
73. Justice SS, Hung C, Theriot JA, Fletcher DA, Anderson GG, Footer MJ, Hultgren SJ. 2004. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 101:1333-1338.
74. Svanborg C, Frendeus B, Godaly G, Hang L, Hedlund M, Wachtler C. 2001. Toll-like receptor signaling and chemokine receptor expression influence the severity of urinary tract infection. J. Infect. Dis. 183(Suppl 1):S61-S65.
75. Ma Z, Gong S, Richard H, Tucker DL, Conway T, Foster JW. 2003. GadE (YhiE) activates glutamate decarboxylase-dependent acid resistance in Escherichia coli K-12. Mol. Microbiol. 49:1309-1320.
76. Ma Z, Richard H, Foster JW. 2003. pH-dependent modulation of cyclic AMP levels and GadW-dependent repression of RpoS affect synthesis of the GadX regulator and Escherichia coli acid resistance. J. Bacteriol. 185: 6852-6859.
77. Raghavan R, Sage A, Ochman H. 2011. Genome-wide identification of transcription start sites yields a novel thermosensing RNA and new cyclic AMP receptor protein-regulated genes in Escherichia coli. J. Bacteriol. 193:2871-2874.
78. Zheng D, Constantinidou C, Hobman JL, Minchin SD. 2004. Identification of the CRP regulon using in vitro and in vivo transcriptional profiling. Nucleic Acids Res. 32:5874-5893.
79. Farr SB, Kogoma T. 1991. Oxidative stress responses in Escherichia coli and Salmonella typhimurium. Microbiol. Rev. 55:561-585.
80. Bus JS, Gibson JE. 1984. Paraquat: model for oxidant-initiated toxicity. Environ. Health Perspect. 55:37-46.
81. Lacour S, Landini P. 2004. SigmaS-dependent gene expression at the onset of stationary phase in Escherichia coli: function of sigmaS-dependent genes and identification of their promoter sequences. J. Bacteriol. 186:7186-7195.
82. Zhang Z, Gosset G, Barabote R, Gonzalez CS, Cuevas WA, Saier MH, Jr. 2005. Functional interactions between the carbon and iron utilization regulators, Crp and Fur, in Escherichia coli. J. Bacteriol. 187:980-990.
83. Wiles TJ, Bower JM, Redd MJ, Mulvey MA. 2009. Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli. PLoS Pathog. 5:e1000697. doi:10.1371/journal.ppat.1000697.
84. Kulesus RR, Diaz-Perez K, Slechta ES, Eto DS, Mulvey MA. 2008. Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli. Infect. Immun. 76:3019-3026.